Publications: Prof Graham Foster
Mahtab MA, Rahman S, Karim MF, Khan M, Foster G, Solaiman S, Afroz S
(
2008
)
.
Epidemiology of hepatitis B virus in Bangladeshi general population
.
HEPATOB PANCREAT DIS
vol.
7
,
(
6
)
595
-
600
.
Uddin G, Faster GR
(
2008
)
.
TITLE: PREVALENCE OF CHRONIC VIRAL HEPATITIS IN SOUTH ASIANS IMMIGRANTS - PEOPLE FROM PAKISTAN HAVE HIGH RATES OF INFECTION WITH HEPATITIS C AND HIGH RATES OF HEPATITIS C INDUCED CIRRHOSIS IN MIDDLE AGE
.
HEPATOLOGY
.
vol.
48
,
533A
-
533A
.
Dakin HA, Foster GR, James ES
(
2008
)
.
Results of a mixed treatment comparison meta-analysis of nucleoside and nucleotide therapies for HBeAG-positive chronic hepatitis B
.
JOURNAL OF HEPATOLOGY
.
vol.
48
,
S256
-
S256
.
Coyle FM, Taylor NF, Monson JP, Drake WM, Foster GR
(
2007
)
.
Non-alcoholic fatty liver disease is associated with transcriptional dysregulation of the corticosteroid metabolising enzyme II beta HSD-1 leading to excess intrahepatic steroid exposure
.
HEPATOLOGY
.
vol.
46
,
741A
-
741A
.
Avraamides G, Ng C-Y, David R, Gu Y, Fazekasova H, Mirenda V, Foster GR, Runkel L et al.
(
2007
)
.
IFN-alpha2 induces leukocyte integrin redistribution, increased adhesion, and migration
.
J Interferon Cytokine Res
vol.
27
,
(
4
)
291
-
303
.
Hibbert L, Foster GR
(
2007
)
.
Interferon induced gene induction and the anti-viral effects of ifn alpha in liver biopsies with hepatitis C: Viral and host responses determine treatment efficacy
.
JOURNAL OF HEPATOLOGY
.
vol.
46
,
S226
-
S227
.
Thomas T, Foster G
(
2007
)
.
Nanomedicines in the treatment of chronic hepatitis C - focus on pegylated interferon alpha-2a
.
INT J NANOMED
vol.
2
,
(
1
)
19
-
24
.
Barton A, Choudhury A, Shanmugasundaram P, McAvinia P, Coyle F, Foster G, Kuitert L
(
2006
)
.
Association between abnormal hepatic enzymes, fatty change in the liver, and acute pulmonary infection in cystic fibrosis
.
THORAX
.
vol.
61
,
II121
-
II122
.
Jones M, Strang AL, Hibbert L, Smith PL, Jacobs MG, Foster GR
(
2006
)
.
HCVNS5A protein - Functional analysis using a BVDV replicon reporter system shows a correlation between in vitro effects on interferon sensitivity and clinical outcome
.
JOURNAL OF HEPATOLOGY
.
vol.
44
,
S153
-
S154
.
Szmaragd C, Foster GR, Manica A, Bartholomeusz A, Nichols RA, Balloux F
(
2006
)
.
Hepatitis B virus mutations involved in clinical outcome
.
JOURNAL OF HEPATOLOGY
.
vol.
44
,
S151
-
S151
.
Swain MG, Foster G, Hadziyannis S, Heathcote J, Jensen D, Lee S, Pockros P, Sulkowski M et al.
(
2005
)
.
Clustering of poor prognostic factors in heavier patients with chronic hepatitis C (CHC): Baseline characteristics and outcomes with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (RBV, COPEGUS (R)) in randomized, international, Phase III trials
.
HEPATOLOGY
.
vol.
42
,
687A
-
688A
.
Scott K, Manunta M, Germain C, Smith P, Jones M, Mitchell P, Dessi D, Bamford KB et al.
(
2005
)
.
Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens
.
IMMUNOLOGY
vol.
116
,
(
2
)
245
-
254
.
Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M
(
2005
)
.
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression
.
J VIROL
vol.
79
,
(
9
)
5414
-
5420
.
FOSTER GR, Feakins R, Kumar P, Alstead E, D'Souza R, Glynn MJ, Mears L, Sabin CA et al.
(
2005
)
.
Natural History of Chronic Hepatitis C Infection: Long Term Follow-up of Asian Patients Infected in Childhood
.
Clin Gastroenterol Hepatol
vol.
3
,
910
-
917
.
Jones M, Germain C, Lechler RI, Lombardi G, Foster GR
(
2004
)
.
Immunomodulatory properties of the type I interferons: Type I interferons can both activate and inhibit Th1 activation
.
HEPATOLOGY
.
vol.
40
,
345A
-
345A
.
Weiland O, Fried MW, Hadziyannis SJ, Foster GR, Messinger D, Freivogel K, Chaneac M
(
2004
)
.
Combination therapy with peginterferon alfa-2a (40kd) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)
.
JOURNAL OF HEPATOLOGY
.
vol.
40
,
154
-
154
.
D'Souza RFC, Glynn MJ, Alstead E, Osonoya C, Foster GR
(
2004
)
.
Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health's educational campaign
.
JOURNAL OF HEPATOLOGY
.
vol.
40
,
139
-
140
.
D'Souza R, Alstead E, Glynn M, Kumar P, Sabin C, Ushiro-Lumb I, Mears L, Feakins R et al.
(
2004
)
.
Natural history of chronic hepatitis C infection: Long term follow up of Asian patients infected in childhood
.
GUT
.
vol.
53
,
A81
-
A82
.
Nkhoma ANS, Macey M, Foster GR
(
2004
)
.
Transition from acute to chronic viral infections - A tissue culture model using respiratory syncitial virus infected cells
.
GUT
.
vol.
53
,
A82
-
A82
.
Foster GR, D'Souza RFC, Main J, Crossey M, Rosenberg W, Murray-Lyon IM, Hayward C
(
2003
)
.
Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile?
.
HEPATOLOGY
.
vol.
38
,
646A
-
646A
.
Foster GR, Fried MW, Hadziyannis SJ, Chaneac M
(
2003
)
.
Treatment of chronic hepatitis C with peginterferon alfa-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)): Patient age has a marked influence on the individual estimated probability of achieving a sustained virological response
.
HEPATOLOGY
.
vol.
38
,
246A
-
246A
.